Hostname: page-component-848d4c4894-p2v8j Total loading time: 0 Render date: 2024-06-09T15:07:04.590Z Has data issue: false hasContentIssue false
  • English
  • Français

The response to inactivated influenza A (H3N2) vaccines: the development and effect of antibodies to the surface antigens

Published online by Cambridge University Press:  15 May 2009

A. J. Smith  and
Joan R. Davies
A. J. Smith
Affiliation:
Public Health Laboratory, St Luke's Hospital, Guildford GU1 3NT, Surrey
Joan R. Davies
Affiliation:
Public Health Laboratory, St Luke's Hospital, Guildford GU1 3NT, Surrey
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A controlled trial of influenza vaccines in a boys' public school from November 1970 to October 1975 provided an opportunity to study the response to vaccine and the effect on subsequent natural challenge in boys with differing natural experience of influenza A strains. The response to influenza A (H3N2) vaccines was assessed by estimating homotypic and heterotypic antibodies to the surface antigens. Previous natural experience of influenza A was found to influence vaccine response and the effect of natural challenge. The antibody response to revaccination with the same strain showed a progressively poorer response to second and third doses. The protective effect of naturally acquired and vaccine-induced antibodies was assessed during two outbreaks of influenza A which occurred in the trial period.

Type
Research Article
Information
Journal of Hygiene , Volume 78 , Issue 3 , June 1977 , pp. 363 - 375
Copyright
Copyright © Cambridge University Press 1977

References

REFERENCES

André, F. E., Uytterschaut, P., Niculescu, I. T. I., Virlan, G., Zilisteanu, E., Smerdel, S. & Vodopija, I. (1976). Placebo-controlled double-blind clinical studies on the efficacy of different influenza vaccines assessed by experimental and natural infection. Postgraduate Medical Journal 52, 352.CrossRefGoogle ScholarPubMed
Hoskins, T. W., Davies, J. R., Allchin, A., Miller, C. L. & Pollock, T. M. (1973). Controlled trial of inactivated influenza vaccine containing the A Hong Kong strain during an outbreak of influenza due to the A/England/42/72 strain. Lancet ii, 116.CrossRefGoogle Scholar
Hoskins, T. W., Davies, J. R., Smith, A. J., Allchin, A., Miller, C. L. & Pollock, T. M. (1976). Influenza at Christ's Hospital, March 1974. Lancet i, 105.CrossRefGoogle Scholar
Kaye, H. S., Dowdle, W. R. & McQueen, J. L. (1969). Studies on inactivated influenza vaccine. 1. The effect of dosage on antibody response and protection against homotypic and heterotypic challenge in mice. American Journal of Epidemiology 90, 162.CrossRefGoogle Scholar
MacKenzie, J. S., MacKenzie, I., Lloyd, J. & Dent, V. (1975). Comparative trials of live attenuated and detergent split influenza virus vaccines. Journal of Hygiene 75, 425.CrossRefGoogle ScholarPubMed
McLaren, C., Potter, C. W. & Jennings, R. (1974). Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection and immunization. Journal of Hygiene 73, 389.CrossRefGoogle Scholar
Mair, H. J., Sansome, D. A. W. & Tillett, H. E. (1974). A controlled trial of inactivated monovalent influenza A vaccines in general practice. Journal of Hygiene 73, 317.CrossRefGoogle ScholarPubMed
Miller, D. L., Reid, D., Diamond, J. R., Pereira, M. S. & Chakraverty, P. (1973). Hong Kong influenza in the Royal Air Force 1968–70. Journal of Hygiene 71, 535.CrossRefGoogle ScholarPubMed
Mostow, S. R., Dowdle, W. R., Schoenbaum, S. C., Coleman, M. T. & Kaye, H. S. (1973). Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultra-centrifugation. Postgraduate Medical Journal 49, 152.CrossRefGoogle Scholar
Pereira, M. S., Chakraverty, P., Schild, G. C., Coleman, M. T. & Dowdle, W. R. (1972). Prevalence of antibody to current influenza viruses and effect of vaccination on antibody responses. British Medical Journal, iv, 701.CrossRefGoogle Scholar
Potter, C. W., Jennings, R., McLaren, C.Edey, D. & Stuart-Harris, C. H. (1975). A new surface-antigen-adsorbed influenza virus vaccine. Journal of Hygiene 75, 353.CrossRefGoogle ScholarPubMed
Slepushkin, A. N., Schild, G. C., Beare, A. S., Chinn, S. & Tyrrell, D. A. J. (1971). Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. Journal of Hygiene 69, 571.Google ScholarPubMed
Smith, A. J. & Davies, J. R. (1976). Natural infection with influenza A (H3N2). The development, persistence and effect of antibodies to the surface antigens. Journal of Hygiene 77, 271.CrossRefGoogle Scholar
Smith, J. W. G., Fletcher, W. B., Peters, M., Westwood, M. & Perkins, F. J. (1975). Response to influenza vaccine in adjuvant 65–4. Journal of Hygiene 74, 251.CrossRefGoogle ScholarPubMed
Smith, J. W. G., Fletcher, W. B. & Wherry, P. J. (1976). Vaccination in the control of influenza. Postgraduate Medical Journal 52, 399.CrossRefGoogle ScholarPubMed
Stiver, H. G., Graves, P., Eickhoff, T. C. & Meiklejohn, G. (1973). Efficacy of ‘Hong Kong’ vaccine in preventing ‘England’ variant influenza A in 1972. New England Journal of Medicine 289, 1267.CrossRefGoogle ScholarPubMed
Tyrrell, D. A. J. (1976). Assessment of vaccine efficacy by challenge studies in man. Postgraduate Medical Journal 52, 379.CrossRefGoogle ScholarPubMed